5 recruiting. 5 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Recruiting 5 |
| Phase 2 | 5 | Recruiting 5 |
Follow Vision Disorders: new trials by email Literature Review of Vision Disorders trials Research Report on Vision Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Psilocybin for Amblyopia - Targeting Critical Periods in Humans Amblyopia Therapy, 1 mg Psilocybin, 5 mg Psilocybin - Amblyopia | Phase 1 / Phase 2 | Recruiting | Johns Hopkins University | 24 | 2026-11-01 | 2026-11-05 |
| Valproate for the Treatment of Residual Amblyopia Valproate, Placebo, Patch - Amblyopia, Amblyopia Unilateral | Phase 1 / Phase 2 | Recruiting | Boston Children's Hospital | 28 | 2026-07-01 | 2026-07-30 |
| A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO) OpCT-001 - Primary Photoreceptor Disease, Retinitis Pigmentosa (RP) | Phase 1 / Phase 2 | Recruiting | BlueRock Therapeutics | 54 | 2025-03-10 | 2026-10-15 |
| Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa AAVB-081 - Usher Syndrome, Type 1B | Phase 1 / Phase 2 | Recruiting | AAVantgarde Bio Srl | 15 | 2024-07-02 | 2025-05-02 |
| Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. Eyecyte-RPE™ - Retinal Disease, Macular Degeneration | Phase 1 / Phase 2 | Recruiting | Eyestem Research Pvt. Ltd. | 54 | 2024-06-04 | 2024-09-24 |
Amblyopia (2) · Retinitis Pigmentosa (2) · Usher Syndromes (2) · Anisometropia (1) · Cone-Rod Dystrophies (1) · Eye Diseases (1) · Geographic Atrophy (1) · Macular Degeneration (1) · Retinal Degeneration (1) · Retinal Diseases (1) · Usher syndrome, type 1B (1)
Nervous System Diseases (5) · Neurologic Manifestations (5) · Pathological Conditions, Signs and Symptoms (5) · Sensation Disorders (5) · Signs and Symptoms (5) · Eye Diseases (4) · Abnormalities, Multiple (2) · Blindness (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Deaf-Blind Disorders (2) · Deafness (2)
Mycophenolic Acid (1) · Psilocybin (1) · Tacrolimus (1) · Transdermal Patch (1) · Valproic Acid (1)
AAVantgarde Bio Srl (1) · BlueRock Therapeutics (1) · Boston Children's Hospital (1) · Eyestem Research Pvt. Ltd. (1) · Johns Hopkins University (1)
United States (3) · India (1) · Italy (1) · United Kingdom (1)
Eric D Gaier, MD, PhD (1) · Frederick Barrett, MD (1)